Qilu Hospital of Shandong University — Jinan

Public research footprint of Qilu Hospital of Shandong University, compiled from the ClinicalTrials.gov public registry.

603

Registered studies

302

Active

188

Recruiting now

138

Completed

Stopped or withdrawn

Most-studied conditions

B Cell Acute Lymphoblastic Leukemia (B-ALL) · Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Acute Respiratory Distress Syndrome (ARDS) · Ischemic Stroke; Ischemic Attack, Transient

Recently updated registry entries

NCT06935357 — A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin… (Recruiting)
NCT06097260 — Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for… (Terminated)
NCT07139301 — Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Qilu Hospital of Shandong University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.